Novavax
NVAX
#5117
Rank
NZ$3.16 B
Marketcap
NZ$19.18
Share price
-0.14%
Change (1 day)
51.76%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2023 (TTM): NZ-$11.79

According to Novavax's latest financial reports the company's current EPS (TTM) is NZ-$2.71. In 2022 the company made an earnings per share (EPS) of NZ-$14.79 an increase over its 2021 EPS that were of NZ-$41.49.

EPS history for Novavax from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$11.79-20.26%
2022NZ-$14.79-64.36%
2021NZ-$41.49243%
2020NZ-$12.1019.75%
2019NZ-$10.10-43.86%
2018NZ-$17.99-19.84%
2017NZ-$22.45-38.83%
2016NZ-$36.7074.58%
2015NZ-$21.0263.89%
2014NZ-$12.8316.13%
2013NZ-$11.0440.91%
2012NZ-$7.8429.41%
2011NZ-$6.06-50%
2010NZ-$12.11-27.66%
2009NZ-$16.75-11.32%
2008NZ-$18.88-7.02%
2007NZ-$20.3146.15%
2006NZ-$13.8950%
2005NZ-$9.26-63.38%
2004NZ-$25.3020.34%
2003NZ-$21.02-35.87%
2002NZ-$32.78113.95%
2001NZ-$15.32-33.85%
2000NZ-$23.16109.68%
1999NZ-$11.04-40.38%
1998NZ-$18.5330%
1997NZ-$14.25-9.007199254741E+17%
1996NZ$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.35-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.90-539.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$5.13-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ-$4.69 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.75 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$3.60-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ-$0.78-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.57-5.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$6.13 126.32%๐Ÿ‡บ๐Ÿ‡ธ USA